65 related articles for article (PubMed ID: 7923175)
21. Promoter of the human NF-kappa B p50/p105 gene. Regulation by NF-kappa B subunits and by c-REL.
Cogswell PC; Scheinman RI; Baldwin AS
J Immunol; 1993 Apr; 150(7):2794-804. PubMed ID: 8454856
[TBL] [Abstract][Full Text] [Related]
22. Effects of vomitoxin (deoxynivalenol) on transcription factor NF-kappa B/Rel binding activity in murine EL-4 thymoma and primary CD4+ T cells.
Ouyang YL; Li S; Pestka JJ
Toxicol Appl Pharmacol; 1996 Oct; 140(2):328-36. PubMed ID: 8887449
[TBL] [Abstract][Full Text] [Related]
23. Characterization of NF(P), the nuclear factor that interacts with the regulatory P sequence (5'-CGAAAATTTCC-3') of the human interleukin-4 gene: relationship to NF-kappa B and NF-AT.
Matsuda I; Masuda ES; Tsuboi A; Behnam S; Arai N; Arai K
Biochem Biophys Res Commun; 1994 Mar; 199(2):439-46. PubMed ID: 8135784
[TBL] [Abstract][Full Text] [Related]
24. rel/NF-kappa B nuclear complexes that bind kB sites in the murine c-rel promoter are required for constitutive c-rel transcription in B-cells.
Grumont RJ; Richardson IB; Gaff C; Gerondakis S
Cell Growth Differ; 1993 Sep; 4(9):731-43. PubMed ID: 8241021
[TBL] [Abstract][Full Text] [Related]
25. The human B-cell lymphoma cell line RC-K8 has multiple genetic alterations that dysregulate the Rel/NF-kappaB signal transduction pathway.
Kalaitzidis D; Davis RE; Rosenwald A; Staudt LM; Gilmore TD
Oncogene; 2002 Dec; 21(57):8759-68. PubMed ID: 12483529
[TBL] [Abstract][Full Text] [Related]
26. Differential nuclear expression of enhancer A DNA-binding proteins in human first trimester trophoblast cells.
Boucraut J; Hawley S; Robertson K; Bernard D; Loke YW; Le Bouteiller P
J Immunol; 1993 May; 150(9):3882-94. PubMed ID: 8473737
[TBL] [Abstract][Full Text] [Related]
27. HTLV-I encoded Tax in association with NF-kappa B precursor p105 enhances nuclear localization of NF-kappa B p50 and p65 in transfected cells.
Watanabe M; Muramatsu M; Hirai H; Suzuki T; Fujisawa J; Yoshida M; Arai K; Arai N
Oncogene; 1993 Nov; 8(11):2949-58. PubMed ID: 8414497
[TBL] [Abstract][Full Text] [Related]
28. Suppression of NF-kappaB activation in normal T cells by supernatant fluid from human renal cell carcinomas.
Kim HJ; Park JK; Kim YG
J Korean Med Sci; 1999 Jun; 14(3):299-303. PubMed ID: 10402173
[TBL] [Abstract][Full Text] [Related]
29. Impaired activation of NFkappaB in T cells from a subset of renal cell carcinoma patients is mediated by inhibition of phosphorylation and degradation of the inhibitor, IkappaBalpha.
Ling W; Rayman P; Uzzo R; Clark P; Kim HJ; Tubbs R; Novick A; Bukowski R; Hamilton T; Finke J
Blood; 1998 Aug; 92(4):1334-41. PubMed ID: 9694722
[TBL] [Abstract][Full Text] [Related]
30. Increased nuclear factor-kappa B activation is related to the tumor development of renal cell carcinoma.
Oya M; Takayanagi A; Horiguchi A; Mizuno R; Ohtsubo M; Marumo K; Shimizu N; Murai M
Carcinogenesis; 2003 Mar; 24(3):377-84. PubMed ID: 12663495
[TBL] [Abstract][Full Text] [Related]
31. Renal cell carcinoma-derived gangliosides suppress nuclear factor-kappaB activation in T cells.
Uzzo RG; Rayman P; Kolenko V; Clark PE; Cathcart MK; Bloom T; Novick AC; Bukowski RM; Hamilton T; Finke JH
J Clin Invest; 1999 Sep; 104(6):769-76. PubMed ID: 10491412
[TBL] [Abstract][Full Text] [Related]
32. Alterations in NFkappaB activation in T lymphocytes of patients with renal cell carcinoma.
Uzzo RG; Clark PE; Rayman P; Bloom T; Rybicki L; Novick AC; Bukowski RM; Finke JH
J Natl Cancer Inst; 1999 Apr; 91(8):718-21. PubMed ID: 10218511
[No Abstract] [Full Text] [Related]
33. Signals leading to the activation of NF-kappa B transcription factor are stronger in neonatal than adult T lymphocytes.
Kilpinen S; Henttinen T; Lahdenpohja N; Hulkkonen J; Hurme M
Scand J Immunol; 1996 Jul; 44(1):85-8. PubMed ID: 8693296
[TBL] [Abstract][Full Text] [Related]
34. Mechanisms of immune evasion by renal cell carcinoma: tumor-induced T-lymphocyte apoptosis and NFkappaB suppression.
Ng CS; Novick AC; Tannenbaum CS; Bukowski RM; Finke JH
Urology; 2002 Jan; 59(1):9-14. PubMed ID: 11796271
[No Abstract] [Full Text] [Related]
35. NF-κB subunits RelA and c-Rel selectively control CD4+ T cell function in multiple sclerosis and cancer.
Lalle G; Lautraite R; Bouherrou K; Plaschka M; Pignata A; Voisin A; Twardowski J; Perrin-Niquet M; Stéphan P; Durget S; Tonon L; Ardin M; Degletagne C; Viari A; Belgarbi Dutron L; Davoust N; Postler TS; Zhao J; Caux C; Caramel J; Dalle S; Cassier PA; Klein U; Schmidt-Supprian M; Liblau R; Ghosh S; Grinberg-Bleyer Y
J Exp Med; 2024 Jun; 221(6):. PubMed ID: 38563819
[TBL] [Abstract][Full Text] [Related]
36. NF-κB in Cancer Immunity: Friend or Foe?
Lalle G; Twardowski J; Grinberg-Bleyer Y
Cells; 2021 Feb; 10(2):. PubMed ID: 33572260
[TBL] [Abstract][Full Text] [Related]
37. Arginase: A Multifaceted Enzyme Important in Health and Disease.
Caldwell RW; Rodriguez PC; Toque HA; Narayanan SP; Caldwell RB
Physiol Rev; 2018 Apr; 98(2):641-665. PubMed ID: 29412048
[TBL] [Abstract][Full Text] [Related]
38. Challenges and future perspectives of T cell immunotherapy in cancer.
de Aquino MT; Malhotra A; Mishra MK; Shanker A
Immunol Lett; 2015 Aug; 166(2):117-33. PubMed ID: 26096822
[TBL] [Abstract][Full Text] [Related]
39. Metabolism of L-arginine by myeloid-derived suppressor cells in cancer: mechanisms of T cell suppression and therapeutic perspectives.
Raber P; Ochoa AC; Rodríguez PC
Immunol Invest; 2012; 41(6-7):614-34. PubMed ID: 23017138
[TBL] [Abstract][Full Text] [Related]
40. Targeted therapy in renal cancer.
Dorff TB; Goldkorn A; Quinn DI
Ther Adv Med Oncol; 2009 Nov; 1(3):183-205. PubMed ID: 21789121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
